Startup Digest: Genetics (January - March 2019)
Hi, habrauzers. I am reviewing the American venture rounds, I will share with you interesting projects that surprised me and, hopefully, will surprise you.
During that time, while I am following innovative startups, I began to notice a rapid trend in the development of genetics and biotechnology. Biotechnological start-ups form the bright immortal future that I want for my body, and at the current moment I see it as quite possible. Humanity is definitely able to develop replaceable components (organs, vessels, cells) in the next 20-30 years. I saw: bio-extremities, exoskeletons, cell banks, stem cell treatments, genetic scissors - and this is a small part of what is already being studied in China or the USA.
edigene.com / Description on Crunchbase
> EdiGene is a dedicated to the development of genome editing technology for human health.
The Chinese are developing gene editing technology to integrate it directly into treatment. The bottom line is, guys, that hereditary, tumor, viral diseases - all this can be treated at the molecular level.
Series A / Feb 6, 2019 / $ 10M
-
genomicprediction.com / Crunchbase Description
> Genomic Prediction provides advanced genetic testing for IVF.
The startup has an improved technology for testing the genome of the embryo in order to predict the most healthy genetic makeup. This process is necessary for artificial insemination, which is one way to avoid partners' genetic diseases (well, like you don’t want to look for another wife, you can fool nature a little)
Seed / Jan 31, 2019 / $ 4.5M
-
gencove.com / Description on Crunchbase
> Gencove's low -pass sequencing platforms delivers whole genome discovery at the cost of genotyping arrays.
Gencove is developing a cost-effective way of sequencing (determining) the genome without going through the entire chain. It turns out that deciphering the entire gene is not at all quick and often not necessary: you can take a part and play with it, hang out, and smear yourself with scientific articles.
In addition, they have the technology of capturing certain sets of areas that are important in some current research. Clear pricing, fashionable landos, medium articles are good hipster scientists.
Series A / Mar 13, 2019 / $ 3M
During that time, while I am following innovative startups, I began to notice a rapid trend in the development of genetics and biotechnology. Biotechnological start-ups form the bright immortal future that I want for my body, and at the current moment I see it as quite possible. Humanity is definitely able to develop replaceable components (organs, vessels, cells) in the next 20-30 years. I saw: bio-extremities, exoskeletons, cell banks, stem cell treatments, genetic scissors - and this is a small part of what is already being studied in China or the USA.
edigene.com / Description on Crunchbase
> EdiGene is a dedicated to the development of genome editing technology for human health.
The Chinese are developing gene editing technology to integrate it directly into treatment. The bottom line is, guys, that hereditary, tumor, viral diseases - all this can be treated at the molecular level.
Series A / Feb 6, 2019 / $ 10M
-
genomicprediction.com / Crunchbase Description
> Genomic Prediction provides advanced genetic testing for IVF.
The startup has an improved technology for testing the genome of the embryo in order to predict the most healthy genetic makeup. This process is necessary for artificial insemination, which is one way to avoid partners' genetic diseases (well, like you don’t want to look for another wife, you can fool nature a little)
Seed / Jan 31, 2019 / $ 4.5M
-
gencove.com / Description on Crunchbase
> Gencove's low -pass sequencing platforms delivers whole genome discovery at the cost of genotyping arrays.
Gencove is developing a cost-effective way of sequencing (determining) the genome without going through the entire chain. It turns out that deciphering the entire gene is not at all quick and often not necessary: you can take a part and play with it, hang out, and smear yourself with scientific articles.
In addition, they have the technology of capturing certain sets of areas that are important in some current research. Clear pricing, fashionable landos, medium articles are good hipster scientists.
Series A / Mar 13, 2019 / $ 3M
PS
If you are interested not only in reviews of venture rounds, but also bigdata analytics and the basic principles of startups, subscribe to my channel in the cart, the link to which can be found in the profile.